Norwich Ventures is a Boston, Massachusetts–based venture capital firm founded in 2017 that invests in early-stage life sciences and technology companies, particularly in biotechnology, therapeutics, diagnostics, digital health and related scientific innovation sectors. The firm partners with founders and scientific teams to provide capital and strategic support through seed and Series A financings, helping companies advance technology development and navigate scientific, regulatory and commercial challenges. Norwich Ventures emphasizes deep domain expertise and active engagement with portfolio companies to accelerate translational research toward commercial impact. Its investment activities are primarily U.S.-focused, and it collaborates with co-investors in venture financings across healthcare and emerging technology landscapes.